Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,723.30
+114.90 (2.49%)
At close: Jan 22, 2026
Pfizer Market Cap
Pfizer has a market cap or net worth of 216.08 billion as of January 23, 2026. Its market cap has decreased by -7.90% in one year.
Market Cap
216.08B
Enterprise Value
189.94B
Revenue
23.75B
Ranking
n/a
PE Ratio
25.74
Stock Price
4,723.30
Market Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 216.08B, an increase of 554.48%. That is a compound annual growth rate of 7.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 210.03B | -7.95% |
| Dec 31, 2025 | 228.18B | -5.56% |
| Dec 31, 2024 | 241.62B | 23.72% |
| Dec 29, 2023 | 195.29B | -3.67% |
| Dec 30, 2022 | 202.74B | -12.34% |
| Dec 31, 2021 | 231.27B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 403.16B |
| J. B. Chemicals & Pharmaceuticals | 297.75B |
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 153.37B |
| Granules India | 138.61B |
| Caplin Point Laboratories | 132.36B |
| Rubicon Research | 109.49B |
| Sanofi India | 93.40B |